Tacrolimus and Aloe drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tacrolimus (tacrolimus) and Aloe (aloe). Common drug interactions include pruritus among females and food interaction among males.

The phase IV clinical study analyzes what interactions people have when they take Tacrolimus and Aloe. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Tacrolimus?

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,160 Tacrolimus users. Check the latest studies of Tacrolimus.

What is Aloe?

Aloe has active ingredients of aloe. eHealthMe is studying from 2,128 Aloe users. Check the latest studies of Aloe.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 22, 2026

19 people who take Tacrolimus and Aloe together, and have interactions are studied.

Tacrolimus and Aloe drug interactions.

What are the common drug interactions of Tacrolimus and Aloe, by gender? *:

female:

  1. Pruritus (severe itching of the skin)
  2. Allergy to arthropod sting
  3. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  4. Contusion (a type of hematoma of tissue in which capillaries)
  5. Discomfort
  6. Dry mouth
  7. Dysgeusia (disorder of the sense of taste)
  8. Dysphagia (a condition in which swallowing is difficult or painful)
  9. Erythema (redness of the skin)
  10. Headache (pain in head)

male:

  1. Food interaction
  2. Immunosuppressant drug level decreased
  3. Rash pruritic (redness with itching)
  4. Abdominal pain upper
  5. Blood glucose increased
  6. Constipation
  7. Headache (pain in head)
  8. Hypertension (high blood pressure)
  9. Myalgia (muscle pain)
  10. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)

What are the common drug interactions of Tacrolimus and Aloe, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Chills (felling of cold)
  2. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  3. Feeling hot
  4. Inflammation
  5. Insomnia (sleeplessness)
  6. Neuralgia (pain in one or more nerves)
  7. Pruritus (severe itching of the skin)
  8. Skin exfoliation (removal of the oldest dead skin cells)

30-39:

n/a

40-49:

  1. Food interaction
  2. Immunosuppressant drug level decreased

50-59:

  1. Headache (pain in head)
  2. Allergy to arthropod sting
  3. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  4. Contusion (a type of hematoma of tissue in which capillaries)
  5. Discomfort
  6. Dry mouth
  7. Dysgeusia (disorder of the sense of taste)
  8. Dysphagia (a condition in which swallowing is difficult or painful)
  9. Erythema (redness of the skin)
  10. Muscle tightness

60+:

  1. Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
  2. Initial insomnia (feeling of inadequate or poor-quality sleep)
  3. Arthralgia (joint pain)
  4. Back pain
  5. Gastrointestinal pain
  6. Injection site bruising
  7. Injection site pruritus (severe itching at injection site)
  8. Injection site swelling
  9. Oral herpes (viral infection of mouth)
  10. Pruritus (severe itching of the skin)

What are the existing conditions these people have? *

  1. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 7 people, 36.84%
  2. Pemphigoid (tense blisters on the skin): 6 people, 31.58%
  3. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 6 people, 31.58%
  4. Iridocyclitis (inflammation of the iris and ciliary body of the eye): 6 people, 31.58%
  5. Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 1 person, 5.26%
  6. Itching: 1 person, 5.26%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.26%
  8. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Tacrolimus and Aloe?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tacrolimus and Aloe:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tacrolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Aloe:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tacrolimus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aloe and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tacrolimus and aloe (the active ingredients of Tacrolimus and Aloe, respectively), and Tacrolimus and Aloe (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: